Sintx Technologies, Inc. (SINT) Financial Statements (2026 and earlier)

Company Profile

Business Address 1885 WEST 2100 STREET
SALT LAKE CITY, UT 84119
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,1403,5983,3406,24514,27325,351
Cash and cash equivalent4,1403,5983,3406,24514,27325,351
Receivables(2)(61)(0)  1,856
Inventory, net of allowances, customer advances and progress billings8255021,221737597487
Inventory8255021,221737597487
Other current assets  10808  
Other undisclosed current assets687722891219158(104)
Total current assets:5,6504,7715,5327,20915,02827,590
Noncurrent Assets
Inventory, Noncurrent 219465333453294388
Operating lease, right-of-use asset2,4583,1594,0942,3092,3851,926
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization4769224,8265,6914,025471
Intangible asset, including goodwill, after accumulated amortization4441621263136
Goodwill302     
Intangible asset, excluding goodwill, after accumulated amortization1421621263136
Other noncurrent assets25980559857736
Total noncurrent assets:3,8564,6429,8338,5646,8122,857
TOTAL ASSETS:9,5069,41315,36515,77321,84030,447
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8041,2852,0402,0521,3671,103
Accounts payable382299636434217194
Accrued liabilities4229861,4041,6181,150909
Debt73246160 109
Derivative instruments and hedges, liabilities8272083045,1263471,238
Other liabilities1,697142 26
Other undisclosed current liabilities398456512738500403
Total current liabilities:3,7331,9822,9068,0782,2142,879
Noncurrent Liabilities
Long-term debt and lease obligation    3681,8981,764
Long-term debt, excluding current maturities    368 287
Liabilities, other than long-term debt2,8443,5373,6871,623  
Other liabilities    2  
Operating lease, liability2,8443,5373,6871,6211,8981,477
Other undisclosed noncurrent liabilities     (1,898)(1,477)
Total noncurrent liabilities:2,8443,5373,6871,9911,8981,764
Total liabilities:6,5775,5196,59310,0694,1124,643
Equity
Equity, attributable to parent2,9293,8948,7725,70417,72825,804
Common stock4013535247245
Treasury stock, value(133)     
Additional paid in capital295,124285,619279,433268,154267,364266,666
Accumulated deficit(292,102)(281,738)(270,714)(262,455)(249,883)(241,107)
Total equity:2,9293,8948,7725,70417,72825,804
TOTAL LIABILITIES AND EQUITY:9,5069,41315,36515,77321,84030,447

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues1,0182,8872,6271,561606594
Cost of revenue(557)(811)(784)(265)(449)(475)
Gross profit:4612,0761,8431,296157119
Operating expenses(11,182)(16,123)(15,201)(12,631)(10,777)(8,623)
Operating loss:(10,721)(14,047)(13,358)(11,335)(10,620)(8,504)
Nonoperating income (expense)3573,0235,099(704)1,8451,475
Other nonoperating income313917382143282
Interest and debt expense   (2)(17) (2)
Loss from continuing operations before equity method investments, income taxes:(10,364)(11,024)(8,261)(12,056)(8,775)(7,031)
Other undisclosed income from continuing operations before income taxes   217 2
Loss from continuing operations:(10,364)(11,024)(8,259)(12,039)(8,775)(7,029)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(8,775)(7,029)
Net loss attributable to parent:(10,364)(11,024)(8,259)(12,039)(8,775)(7,029)
Preferred stock dividends and other adjustments   (26)(4,450) (9,565)
Other undisclosed net loss available to common stockholders, basic(6,719)     
Net loss available to common stockholders, basic:(17,083)(11,024)(8,285)(16,489)(8,775)(16,594)
Dilutive securities, effect on basic earnings per share  (291)(5,320)(2,807)(696)(2,293)
Other undisclosed net loss available to common stockholders, diluted      (1)
Net loss available to common stockholders, diluted:(17,083)(11,315)(13,605)(19,296)(9,471)(18,888)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(10,364)(11,024)(8,259)(12,039)(8,775)(7,029)
Comprehensive loss, net of tax, attributable to parent:(10,364)(11,024)(8,259)(12,039)(8,775)(7,029)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: